Series date: 
01/01/2026 - 11:00am EST to 12/31/2026 - 12:00pm EST

Series Description

The International Rare Brain Tumor Board is a monthly meeting that brings a multidisciplinary team of experts (neuropathologist, neurosurgeons, neuro radiologist, neuro-oncologist, radiation oncologist, etc) from both pediatric and adult subspecialties to discuss recently diagnosed cases of patients with Rare Brain Tumors. We compare the available treatment regimens, including open study protocols, and determine the best management options.

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physicians
  • Physician Assistants
  • Social Workers

Learning Objectives

  1. Enhance Knowledge of Rare Tumor Pathology and Diagnostics: Participants will gain a deeper understanding of the unique characteristics, diagnostic challenges, and emerging technologies used to identify rare brain tumors, improving accuracy in diagnosis.
  2. Foster Collaborative Decision-Making in Treatment Planning: Attendees will develop the skills to engage in multidisciplinary discussions, integrating input from oncologists, radiologists, pathologists, and surgeons to create comprehensive, personalized treatment plans.
  3. Establish Best Practices for Managing Rare Brain Tumors: Participants will explore current treatment options, including novel therapies and clinical trials, and work toward establishing standardized protocols for the management of rare brain tumors to ensure best practice.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Children’s National Hospital. Children’s National Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  Children’s National Hospital Accreditation Provider# 4008362 

Credit Designation

Physicians: Children’s National Hospital designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: Children’s National Hospital designates this activity for a maximum of 1.0 LIVE ANCC contact hours.

Social Workers: As a Jointly Accredited Organization, Children’s National Hospital is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 General continuing education credits.

Disclosure of Relevant Financial Relationships

The planning committee and presenters have no relevant financial relationships with ineligible companies.

Financial and In-Kind Commercial Support

No financial nor in-kind commercial support was received for this educational activity.

Series location: 
Children's National Hospital Virtual Platform
United States

Sessions

Session Date
Rare Brain Tumor Board January 2026 01/06/2026 - 11:00am to 12:00pm EST
Rare Brain Tumor Board February 2026 02/03/2026 - 11:00am to 12:00pm EST
Rare Brain Tumor Board March 2026 03/03/2026 - 11:00am to 12:00pm EST
Rare Brain Tumor Board April 2026 04/07/2026 - 11:00am to 12:00pm EDT
Rare Brain Tumor Board May 2026 05/05/2026 - 11:00am to 12:00pm EDT
Rare Brain Tumor Board June 2026 06/02/2026 - 11:00am to 12:00pm EDT
Rare Brain Tumor Board July 2026 07/07/2026 - 11:00am to 12:00pm EDT
Rare Brain Tumor Board August 2026 08/04/2026 - 11:00am to 12:00pm EDT
Rare Brain Tumor Board September 2026 09/01/2026 - 11:00am to 12:00pm EDT
Rare Brain Tumor Board October 2026 10/06/2026 - 11:00am to 12:00pm EDT

Pages